Heidi Ledford. Show Affiliations »
Abstract
Entities: Disease
Keywords: Diseases; Epidemiology; SARS-CoV-2
Mesh: See more » Antibodies, Monoclonal, Humanized/pharmacologyAntibodies, Monoclonal, Humanized/therapeutic useBetacoronavirus/drug effectsBetacoronavirus/immunologyBetacoronavirus/pathogenicityCOVID-19Clinical Decision-MakingCoronavirus Infections/drug therapyCoronavirus Infections/immunologyCoronavirus Infections/mortalityCoronavirus Infections/pathologyHumansImmunosuppressive Agents/pharmacologyImmunosuppressive Agents/therapeutic useInterleukin-6/antagonists & inhibitorsInterleukin-6/immunologyMacrophages/drug effectsMacrophages/immunologyPandemicsPhysicians/psychologyPneumonia, Viral/drug therapyPneumonia, Viral/immunologyPneumonia, Viral/mortalityPneumonia, Viral/pathologyRandomized Controlled Trials as TopicSARS-CoV-2Steroids/administration & dosageSteroids/adverse effectsSteroids/pharmacologySteroids/therapeutic useT-Lymphocytes/drug effectsT-Lymphocytes/immunologyUncertainty
Substances: See more » Antibodies, Monoclonal, HumanizedImmunosuppressive AgentsInterleukin-6Steroidstocilizumab
Year: 2020 PMID: 32273618 DOI: 10.1038/d41586-020-01056-7
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962